No exact match found for Rigau, Marina,, using Rigau Marina instead...
UAB Digital Repository of Documents 6 records found  Search took 0.02 seconds. 
1.
174 p, 6.1 MB Micro-RNAs in ovarian cancer as tools for diagnosis and therapy / Majem Cavaller, Blanca, autor. ; Santamaria Margalef, Anna, supervisor acadèmic. ; Rigau Resina, Marina, supervisor acadèmic. ; Llauradó i Miravall, Marta, supervisor acadèmic. (Hospital Universitari de la Vall d'Hebron) ; Miró, Rosa, supervisor acadèmic. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia.
El càncer d'ovari (CO) és la cinquena causa del càncer en dones i la principal causa de mort entre les malalties ginecològiques. Els símptomes inespecífics i les eines diagnòstiques actualment insuficients no detecten la malaltia en estadis inicials, quan la supervivència és del 90%. [...]
Ovarian cancer (OC) is the fifth cause of cancer in women and the leading cause of death among gynecological malignancies in developed countries. The unspecific symptoms and currently insufficient diagnostic tools fail to detect the disease at an early stage, when the 5-years survival is 90%. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2017.  
2.
211 p, 8.9 MB Nuevas moléculas asociadas al cáncer de ovario para la mejora de su diagnóstico y tratamiento / Lanau Angulo, Lucia, autor. ; Reventós i Puigjaner, Jaume, supervisor acadèmic. ; Rigau Resina, Marina, supervisor acadèmic. ; Santamaria Margalef, Anna, supervisor acadèmic. ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia.
El cáncer de ovario (CO) es el cáncer ginecológico más letal y la quinta causa de muerte por cáncer en mujeres del mundo occidental. Debido a la inespecificidad de los síntomas y a la falta de técnicas diagnósticas eficaces, el CO es detectado en el 85% de los casos en estadio avanzado, resultando en una tasa de supervivencia a 5 años del 28%. [...]
Ovarian cancer (OC) is the most lethal gynaecological malignancy and the fifth leading cause of cancer deaths in women in the Western world. Due to the lack of specificity and lack of effective diagnostic techniques, OC is detected in 85% of cases at advanced stages, resulting in a 5-year survival rate of 28%. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2017.  
3.
60 p, 3.6 MB Biological properties of extracellular vesicles and their physiological functions / Yáñez-Mó, María (Universidad Autónoma de Madrid. Departamento de Biología Molecular) ; Siljander, Pia R.-M. (University of Helsinki. Department of Biosciences) ; Andreu, Zoraida (Universidad Autónoma de Madrid. Departamento de Biología Molecular) ; Zavec, Apolonija Bedina (National Institute of Chemistry (Ljubljana)) ; Borràs, Francesc E. (Institut Germans Trias i Pujol) ; Buzas, Edit I. (Semmelweis University. Department of Genetics, Cell- and Immunobiology) ; Buzas, Krisztina (University of Szeged. Faculty of Dentistry) ; Casal, Enriqueta (CIC bioGUNE) ; Cappello, Francesco (Euro-Mediterranean Institute of Science and Technology (Palermo)) ; Carvalho, Joana (Institute of Molecular Pathology and Immunology of the University of Porto) ; Colás, Eva (Vall d'Hebron Institut de Recerca) ; Cordeiro da Silva, Anabela (University of Porto. Department of Biological Sciences,) ; Fais, Stefano (National Institute of Health. Department of Therapeutic Research and Medicines Evaluation (Rome)) ; Falcon Perez, Juan M. (CIC bioGUNE) ; Ghobrial, Irene M. (Dana-Farber Cancer Institute) ; Giebel, Bernd (University Hospital Essen. Institute for Transfusion Medicine) ; Gimona, Mario (Universitätsklinikum. Department of Blood Group Serology and Transfusion Medicine (Salzburg)) ; Graner, Michael (University of Colorado Denver. Department of Neurosurgery) ; Gursel, Ihsan (Bilkent University. Department of Molecular Biology and Genetics) ; Gursel, Mayda (Middle East Technical University. Department of Biological Sciences) ; Heegaard, Niels H. H. (Statens Serum Institut. Department of Clinical Biochemistry, Immunology & Genetics) ; Hendrix, An (Ghent University Hospital. Department of Radiation Oncology and Experimental Cancer Research) ; Kierulf, Peter (Oslo University Hospital. Department of Medical Biochemistry) ; Kokubun, Katsutoshi (Dana-Farber Cancer Institute) ; Kosanovic, Maja (University of Belgrade. Institute for the Application of Nuclear Energy) ; Kralj-Iglic, Veronika (University of Ljubljana. Faculty of Health Sciences) ; Krämer-Albers, Eva-Maria (University of Mainz. Molecular Cell Biology and Focus Program Translational Neurosciences) ; Laitinen, Saara (Finnish Red Cross Blood Service) ; Lässer, Cecilia (University of Gothenburg. Institute of Medicine at the Sahlgrenska Academy) ; Lener, Thomas (Universitätsklinikum. Department of Blood Group Serology and Transfusion Medicine) ; Ligeti, Erzsébet (Semmelweis University. Department of Physiology) ; Linē, Aija (Latvian Biomedical Research and Study Centre) ; Lipps, Georg (University of Applied Sciences and Arts Northwestern Switzerland. Institute of Chemistry and Bioanalytics) ; Llorente, Alicia (Oslo University Hospital – The Norwegian Radium Hospital. Institute for Cancer Research) ; Lötvall, Jan (University of Gothenburg. Institute of Medicine at the Sahlgrenska Academy) ; Manček-Keber, Mateja (EN→FIST Centre of Excellence (Ljubljana)) ; Marcilla, Antonio (Universitat de Valencia. Departamento de Biología Celular y Parasitologia) ; Mittelbrunn, Maria (Centro Nacional de Investigaciones Cardiovasculares (Madrid)) ; Nazarenko, Irina (University of Freiburg. Institute for Environmental Health Sciences and Hospital Infection Control Medical Center) ; Nolte-'t Hoen, Esther N.M. (Utrecht University. Department of Biochemistry and Cell Biology) ; Nyman, Tuula A. (University of Helsinki. Institute of Biotechnology) ; O'Driscoll, Lorraine (Trinity College Dublin. School of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute) ; Olivan, Mireia (Vall d'Hebron Institut de Recerca) ; Oliveira, Carla (University of Porto. Department of Pathology and Oncology) ; Pállinger, Éva (Semmelweis University. Department of Genetics, Cell- and Immunobiology) ; del Portillo, Hernando A. (Institució Catalana de Recerca i Estudis Avançats) ; Reventós, Jaume (Vall d'Hebron Institut de Recerca) ; Rigau, Marina (Vall d'Hebron Institut de Recerca) ; Rohde, Eva (Universitätsklinikum. Department of Blood Group Serology and Transfusion Medicine (Salzburg)) ; Sammar, Marei (ORT Braude College. Department of Biotechnology Engineering) ; Sánchez-Madrid, Francisco (Hospital de la Princesa. Instituto de Investigaciones Sanitarias Princesa) ; Santarém, N. (IBMC – Instituto de Biologia Molecular e Celular, Universidade do Porto) ; Schallmoser, Katharina (Uniklinikum Salzburg. University Clinic of Blood Group Serology and Transfusion Medicine) ; Ostenfeld, Marie Stampe (Aarhus University Hospital. Departmnet of Molecular Medicine) ; Stoorvogel, Willem (Utrecht University. Department of Biochemistry and Cell Biology) ; Stukelj, Roman (University of Ljubljana. Laboratory of Clinical Biophysics) ; Van der Grein, Susanne G. (Utrecht University. Department of Biochemistry and Cell Biology) ; Vasconcelos, M. Helena (University of Porto. Department of Biological Sciences) ; Wauben, Marca H. M. (Utrecht University. Department of Biochemistry and Cell Biology) ; De Wever, Olivier (Ghent University Hospital. Department of Radiation Oncology and Experimental Cancer Research) ; Universitat Autònoma de Barcelona
In the past decade, extracellular vesicles (EVs) have been recognized as potent vehicles of intercellular communication, both in prokaryotes and eukaryotes. This is due to their capacity to transfer proteins, lipids and nucleic acids, thereby influencing various physiological and pathological functions of both recipient and parent cells. [...]
2015 - 10.3402/jev.v4.27066
Journal of extracellular vesicles, Vol. 4 (2015)  
4.
159 p, 2.2 MB Identification and evaluation of molecular biomarkers in urine for the detection of prostate cancer / Sequeiros Fontán, Tamara ; Rigau, Marina, dir. ; Doll, Andreas, dir. ; Morote, Juan, dir. ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
El cáncer de próstata (CP) es una de las mayores causas de muerte entre los hombres de los países desarrollados. Sin embargo, los actuales métodos de diagnóstico presentan una elevada tasa de falsos positivos debido a su baja especificidad, lo que conlleva un elevado número de biopsias de próstata (BPs) practicadas innecesariamente. [...]
Prostate cancer (PCa) is one of the leading causes of death among men in the developed countries. Nevertheless, current methods of diagnosis for PCa have a high rate of false positive results due to a low specificity and, therefore, to many unnecessary prostatic biopsies (PBs). [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2014  
5.
240 p, 9.1 MB Identification of new urine biomarkers for the detection of prostate cancer / Rigau Resina, Marina ; Reventós i Puigjaner, Jaume, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Morote Robles, Juan, dir. (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Doll, Andreas, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
El càncer de pròstata (CP), és la segona causa de mort per malaltia oncològica en els homes del món occidental. S'estima que un de cada sis homes desenvoluparà un càncer d'aquest tipus al llarg de la seva vida. [...]
The prostate gland is a walnut-sized organ of the male urinary-genital tract that is located below the bladder surrounding the urethra and in front of the rectum. The most important disease affecting prostate is prostate cancer (PCa). [...]

Bellaterra : Universitat Autònoma de Barcelona, 2012  
6.
2 p, 153.4 KB Un nou biomarcador per a la detecció del càncer de pròstata en orina / Rigau Resina, Marina (Hospital Universitari de la Vall d'Hebron. Unitat de Recerca Biomèdica i Oncologia Translacional i Pediàtrica)
El càncer de pròstata és el tipus de càncer més freqüent que afecta a la població masculina. El mètode diagnòstic utilitzat actualment és la detecció en sèrum de PSA (antigen prostàtic específic), el tacte rectal i la posterior biòpsia en cas de sospita. [...]
2011
UAB divulga, Juliol 2011, p. 1-2  

See also: similar author names
3 Rigau, M.
4 Rigau, Marina
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.